French nerve stim/ophthalmic implant reimbursement:
This article was originally published in Clinica
Mid-September has seen the publication of two decrees in the French Journal officiel concerning the reimbursement approval and price setting of medical devices sold in the French private sector. The products listed are: Cyberonics Europe's left vagal nerve stimulator, NCP 101, and its VNS bipolar electrodes, models 300-20 and 300-30; and the viscoelastic ophthalmic implants, Ophtalin and Ophtalin Plus, formerly listed under Ciba Vision, now listed under Iotech.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.